SAN DIEGO, Aug. 25, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has closed its previously announced private placement with investors providing for… Read More
Vancouver, British Columbia – August 24, 2020 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function,… Read More
SAN DIEGO, Aug. 21, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has regained compliance with the minimum bid… Read More
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has completed its merger with Adgero… Read More
Vancouver, British Columbia – August 18, 2020 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function,… Read More
